Get started
Author

Mona Omar Mohsen

Observed names: Mohsen, Mona, Mohsen, Mona O, Mohsen, Mona O., Mohsen, Mona Omar Mahmoud, Mona Mohsen, Mona O Mohsen, Mona O. Mohsen
Observed institutions: University of Bern, Anhui Agricultural University, University Hospital of Bern, University of Oxford, National Center for Cancer Care and Research, Allergy Therapeutics (United Kingdom), Weill Cornell Medical College in Qatar, Jenner Institute, Weill Cornell Medicine, University College London, Hamad Medical Corporation, Qatar University, Qatar Foundation
ORCID: 0000-0003-3510-9148
Observed ORCID: 0000-0003-3510-9148
OpenAlex ID: A5083087740
Major findings and recent advances in virus–like particle (VLP)-based vaccines
2017 · Mona O. Mohsen, Lisha Zha, et al. · Seminars in Immunology · 580
On Iron Metabolism and Its Regulation
2021 · Anne-Cathrine S. Vogt, Tasneem Arsiwala, et al. · International Journal of Molecular Sciences · 519
PDF
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
2022 · Queenie Fernandes, Varghese Philipose Inchakalody, et al. · Annals of Medicine · 466
PDF
Virus-like particle vaccinology, from bench to bedside
2022 · Mona O. Mohsen, Martin F. Bachmann · Cellular and Molecular Immunology · 320
PDF
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
2018 · Mona O. Mohsen, Ariane C. Gomes, et al. · Vaccines · 198
PDF
Harnessing Nanoparticles for Immunomodulation and Vaccines
2017 · Ariane Gomes, Mona Mohsen, et al. · Vaccines · 163
PDF
Virus‐like particles for vaccination against cancer
2019 · Mona O. Mohsen, Daniel E. Speiser, et al. · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 127
PDF
The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics”
2020 · Mona O. Mohsen, Gilles Augusto, et al. · Immunological Reviews · 97
PDF
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
2017 · Mona O. Mohsen, Ariane C. Gomes, et al. · Journal of Controlled Release · 90
PDF
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
2023 · Anne-Cathrine S. Vogt, Gary T. Jennings, et al. · International Journal of Molecular Sciences · 88
PDF
In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
2021 · Gilles Augusto, Mona O. Mohsen, et al. · Allergy · 84
PDF
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
2019 · Mona O. Mohsen, Matthew D. Heath, et al. · Journal for ImmunoTherapy of Cancer · 67
PDF
Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
2019 · Gustavo Cabral-Miranda, Stephanie M. Lim, et al. · Vaccines · 63
PDF
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
2021 · Xuelan Liu, Xinyue Chang, et al. · Vaccines · 62
PDF
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
2021 · Martin F. Bachmann, Mona O. Mohsen, et al. · npj Vaccines · 59
PDF
The impact of size on particle drainage dynamics and antibody response
2021 · Simon Zinkhan, Anete Ogrina, et al. · Journal of Controlled Release · 58
PDF
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
2019 · Mona O. Mohsen, Monique Vogel, et al. · Frontiers in Immunology · 58
PDF
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
2018 · Ludger Klimek, Thomas Kündig, et al. · Allergo Journal International · 57
PDF
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
2021 · Mona O. Mohsen, Ina Balke, et al. · Allergy · 54
PDF
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
2021 · Lisha Zha, Xinyue Chang, et al. · Vaccines · 49
PDF
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
2022 · Xinyue Chang, Pascal Krenger, et al. · Frontiers in Immunology · 44
PDF
An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb
2018 · Lisha Zha, Fabiana M.S. Leoratti, et al. · Journal of Allergy and Clinical Immunology · 43
Culpability, blame, and stigma after pregnancy loss in Qatar
2019 · Nadia Omar, Stella Major, et al. · BMC Pregnancy and Childbirth · 41
PDF
New 3-Cyano-2-Substituted Pyridines Induce Apoptosis in MCF 7 Breast Cancer Cells
2016 · Ahmed Malki, Mona Mohsen, et al. · Molecules · 41
PDF
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
2022 · Dominik A. Rothen, Pascal S. Krenger, et al. · Allergy · 40
PDF
Works count: 98
Citation count: 4,153
H-index: 30
I10-index: 55
Year
Topic
Type